Salud financiera de hoja de balance de Vaishali Pharma
Salud financiera controles de criterios 4/6
Vaishali Pharma tiene un patrimonio de accionistas total de ₹677.6M y una deuda total de ₹123.5M, lo que sitúa su ratio deuda-patrimonio en 18.2%. Sus activos y pasivos totales son ₹1.0B y ₹361.9M respectivamente. El BAIT de Vaishali Pharma es de ₹14.4M, por lo que su ratio de cobertura de intereses es de 2. Tiene efectivo e inversiones a corto plazo que ascienden a ₹11.4M.
Información clave
18.2%
Ratio deuda-patrimonio
₹123.46m
Deuda
| Ratio de cobertura de intereses | 2x |
| Efectivo | ₹11.43m |
| Patrimonio | ₹677.63m |
| Total pasivo | ₹361.85m |
| Activos totales | ₹1.04b |
Actualizaciones recientes sobre salud financiera
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Recent updates
Investors Give Vaishali Pharma Limited (NSE:VAISHALI) Shares A 33% Hiding
Nov 15A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹983.9M) de VAISHALI superan a sus pasivos a corto plazo (₹329.7M).
Pasivo a largo plazo: Los activos a corto plazo de VAISHALI (₹983.9M) superan a sus pasivos a largo plazo (₹32.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (16.5%) de VAISHALI se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de VAISHALI ha pasado de 71.9% a 18.2% en los últimos 5 años.
Cobertura de la deuda: El flujo de caja operativo de VAISHALI es negativo, por lo que la deuda no está bien cubierta.
Cobertura de intereses: Los pagos de intereses de la deuda de VAISHALI no están bien cubiertos por el BAIT (2x cobertura).